WO2023249158A1 - Composition de polyéthylène et son procédé de sa préparation - Google Patents
Composition de polyéthylène et son procédé de sa préparation Download PDFInfo
- Publication number
- WO2023249158A1 WO2023249158A1 PCT/KR2022/010367 KR2022010367W WO2023249158A1 WO 2023249158 A1 WO2023249158 A1 WO 2023249158A1 KR 2022010367 W KR2022010367 W KR 2022010367W WO 2023249158 A1 WO2023249158 A1 WO 2023249158A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- weight
- microstructure
- cosmetic composition
- oil
- extract
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 118
- 239000002537 cosmetic Substances 0.000 title claims abstract description 66
- 238000000034 method Methods 0.000 title claims abstract description 28
- 239000003921 oil Substances 0.000 claims description 40
- 235000019198 oils Nutrition 0.000 claims description 40
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 35
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 28
- 239000008213 purified water Substances 0.000 claims description 26
- 235000015112 vegetable and seed oil Nutrition 0.000 claims description 23
- 239000002904 solvent Substances 0.000 claims description 22
- 238000002156 mixing Methods 0.000 claims description 20
- 239000003205 fragrance Substances 0.000 claims description 19
- OIRDTQYFTABQOQ-KQYNXXCUSA-N adenosine Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O OIRDTQYFTABQOQ-KQYNXXCUSA-N 0.000 claims description 18
- 229940015975 1,2-hexanediol Drugs 0.000 claims description 17
- 240000001432 Calendula officinalis Species 0.000 claims description 17
- 229940008099 dimethicone Drugs 0.000 claims description 17
- 239000004205 dimethyl polysiloxane Substances 0.000 claims description 17
- 235000013870 dimethyl polysiloxane Nutrition 0.000 claims description 17
- FHKSXSQHXQEMOK-UHFFFAOYSA-N hexane-1,2-diol Chemical compound CCCCC(O)CO FHKSXSQHXQEMOK-UHFFFAOYSA-N 0.000 claims description 17
- 238000004519 manufacturing process Methods 0.000 claims description 17
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 claims description 17
- 235000005881 Calendula officinalis Nutrition 0.000 claims description 16
- 229920006037 cross link polymer Polymers 0.000 claims description 15
- 239000008158 vegetable oil Substances 0.000 claims description 15
- NCZPCONIKBICGS-UHFFFAOYSA-N 3-(2-ethylhexoxy)propane-1,2-diol Chemical compound CCCCC(CC)COCC(O)CO NCZPCONIKBICGS-UHFFFAOYSA-N 0.000 claims description 14
- 229940100524 ethylhexylglycerin Drugs 0.000 claims description 14
- 235000011187 glycerol Nutrition 0.000 claims description 14
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 13
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 claims description 12
- 229920002385 Sodium hyaluronate Polymers 0.000 claims description 12
- 229940010747 sodium hyaluronate Drugs 0.000 claims description 12
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 claims description 12
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical group O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 11
- AEIJTFQOBWATKX-UHFFFAOYSA-N octane-1,2-diol Chemical compound CCCCCCC(O)CO AEIJTFQOBWATKX-UHFFFAOYSA-N 0.000 claims description 11
- 150000005846 sugar alcohols Polymers 0.000 claims description 11
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 claims description 10
- 150000004676 glycans Chemical class 0.000 claims description 10
- 229960005323 phenoxyethanol Drugs 0.000 claims description 10
- 229920001282 polysaccharide Polymers 0.000 claims description 10
- 239000005017 polysaccharide Substances 0.000 claims description 10
- 239000002126 C01EB10 - Adenosine Substances 0.000 claims description 9
- 239000004215 Carbon black (E152) Substances 0.000 claims description 9
- SNPLKNRPJHDVJA-ZETCQYMHSA-N D-panthenol Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCCO SNPLKNRPJHDVJA-ZETCQYMHSA-N 0.000 claims description 9
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 claims description 9
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims description 9
- 229960005305 adenosine Drugs 0.000 claims description 9
- 239000001649 glycyrrhiza glabra l. absolute Substances 0.000 claims description 9
- 229920006158 high molecular weight polymer Polymers 0.000 claims description 9
- 229930195733 hydrocarbon Natural products 0.000 claims description 9
- 150000002430 hydrocarbons Chemical class 0.000 claims description 9
- 229940051810 licorice root extract Drugs 0.000 claims description 9
- 235000020725 licorice root extract Nutrition 0.000 claims description 9
- 239000011570 nicotinamide Substances 0.000 claims description 9
- 229960003966 nicotinamide Drugs 0.000 claims description 9
- 235000005152 nicotinamide Nutrition 0.000 claims description 9
- 229940101267 panthenol Drugs 0.000 claims description 9
- 235000020957 pantothenol Nutrition 0.000 claims description 9
- 239000011619 pantothenol Substances 0.000 claims description 9
- 239000000843 powder Substances 0.000 claims description 9
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 claims description 8
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 claims description 8
- BNMGUJRJUUDLHW-HCZMHFOYSA-N Madecassoside Chemical compound O([C@@H]1[C@@H](CO)O[C@H]([C@@H]([C@H]1O)O)OC[C@H]1O[C@H]([C@@H]([C@@H](O)[C@@H]1O)O)OC(=O)[C@]12CC[C@H]([C@@H]([C@H]1C=1[C@@]([C@@]3(C[C@@H](O)[C@H]4[C@](C)(CO)[C@@H](O)[C@H](O)C[C@]4(C)[C@H]3CC=1)C)(C)CC2)C)C)[C@@H]1O[C@@H](C)[C@H](O)[C@@H](O)[C@H]1O BNMGUJRJUUDLHW-HCZMHFOYSA-N 0.000 claims description 8
- BNMGUJRJUUDLHW-HLUHVYOBSA-N Madecassoside Natural products C[C@@H]1CC[C@@]2(CC[C@]3(C)C(=CC[C@@H]4[C@@]5(C)C[C@@H](O)[C@H](O)[C@@](C)(CO)[C@@H]5[C@H](O)C[C@@]34C)[C@@H]2[C@H]1C)C(=O)O[C@@H]6O[C@H](CO[C@@H]7O[C@H](CO)[C@@H](O[C@@H]8O[C@H](C)[C@H](O)[C@@H](O)[C@H]8O)[C@H](O)[C@H]7O)[C@@H](O)[C@H](O)[C@H]6O BNMGUJRJUUDLHW-HLUHVYOBSA-N 0.000 claims description 8
- QCYLIQBVLZBPNK-UHFFFAOYSA-N asiaticoside A Natural products O1C(C(=O)C(C)C)=CC(C)C(C2(C(OC(C)=O)CC34C5)C)C1CC2(C)C3CCC(C1(C)C)C45CCC1OC1OCC(O)C(O)C1O QCYLIQBVLZBPNK-UHFFFAOYSA-N 0.000 claims description 8
- 229920002674 hyaluronan Polymers 0.000 claims description 8
- 229960003160 hyaluronic acid Drugs 0.000 claims description 8
- 239000008101 lactose Substances 0.000 claims description 8
- 229940090813 madecassoside Drugs 0.000 claims description 8
- 229920001296 polysiloxane Polymers 0.000 claims description 8
- ULWHHBHJGPPBCO-UHFFFAOYSA-N propane-1,1-diol Chemical compound CCC(O)O ULWHHBHJGPPBCO-UHFFFAOYSA-N 0.000 claims description 8
- 235000001674 Agaricus brunnescens Nutrition 0.000 claims description 7
- 235000021028 berry Nutrition 0.000 claims description 7
- 229920001577 copolymer Polymers 0.000 claims description 7
- 238000001035 drying Methods 0.000 claims description 7
- 229940069445 licorice extract Drugs 0.000 claims description 7
- 239000000377 silicon dioxide Substances 0.000 claims description 7
- AJLNZWYOJAWBCR-OOPVGHQCSA-N (4s)-4-acetamido-5-[[(2s)-1-[[(2s)-1-[[(2s)-5-amino-1-[[(2s)-1-[[(2s)-1-amino-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-1,5-dioxopentan-2-yl]amino]-4-methylsulfanyl-1-oxobutan-2-yl]amino]-4-car Chemical compound OC(=O)CC[C@H](NC(C)=O)C(=C)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCCN=C(N)N)C(N)=O AJLNZWYOJAWBCR-OOPVGHQCSA-N 0.000 claims description 6
- BANXPJUEBPWEOT-UHFFFAOYSA-N 2-methyl-Pentadecane Chemical compound CCCCCCCCCCCCCC(C)C BANXPJUEBPWEOT-UHFFFAOYSA-N 0.000 claims description 6
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 claims description 6
- 229940095094 acetyl hexapeptide-8 Drugs 0.000 claims description 6
- 108010006338 acetyl-glutamyl-glutamyl-methionyl-glutaminyl-arginyl-argininamide Proteins 0.000 claims description 6
- WWZKQHOCKIZLMA-UHFFFAOYSA-N octanoic acid Chemical compound CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 claims description 6
- 239000011863 silicon-based powder Substances 0.000 claims description 6
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 claims description 6
- OGNHOGPWQTWKGQ-VGWMRTNUSA-N (2S)-5-amino-2-[[(2S)-1-[2-[[(2S)-5-amino-2-[[(2S)-1-(2-aminoacetyl)pyrrolidine-2-carbonyl]amino]-5-oxopentanoyl]amino]acetyl]pyrrolidine-2-carbonyl]amino]-5-oxopentanoic acid Chemical compound NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)NCC(=O)N1[C@H](C(=O)N[C@@H](CCC(N)=O)C(O)=O)CCC1 OGNHOGPWQTWKGQ-VGWMRTNUSA-N 0.000 claims description 5
- RJZNPROJTJSYLC-LLINQDLYSA-N (4s)-4-acetamido-5-[[(2s)-1-[[(2s)-1-[[(2s)-5-amino-1-[[(2s)-1-[[(2s)-1-amino-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-1,5-dioxopentan-2-yl]amino]-4-methylsulfanyl-1-oxobutan-2-yl]amino]-4-car Chemical compound OC(=O)CC[C@H](NC(C)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(N)=O RJZNPROJTJSYLC-LLINQDLYSA-N 0.000 claims description 5
- DGSZGZSCHSQXFV-UHFFFAOYSA-N 2,3-bis(2-ethylhexanoyloxy)propyl 2-ethylhexanoate Chemical compound CCCCC(CC)C(=O)OCC(OC(=O)C(CC)CCCC)COC(=O)C(CC)CCCC DGSZGZSCHSQXFV-UHFFFAOYSA-N 0.000 claims description 5
- LEACJMVNYZDSKR-UHFFFAOYSA-N 2-octyldodecan-1-ol Chemical compound CCCCCCCCCCC(CO)CCCCCCCC LEACJMVNYZDSKR-UHFFFAOYSA-N 0.000 claims description 5
- 244000125300 Argania sideroxylon Species 0.000 claims description 5
- 229920002134 Carboxymethyl cellulose Polymers 0.000 claims description 5
- 244000044822 Simmondsia californica Species 0.000 claims description 5
- 235000004433 Simmondsia californica Nutrition 0.000 claims description 5
- BTFJIXJJCSYFAL-UHFFFAOYSA-N arachidyl alcohol Natural products CCCCCCCCCCCCCCCCCCCCO BTFJIXJJCSYFAL-UHFFFAOYSA-N 0.000 claims description 5
- BQMNFPBUAQPINY-UHFFFAOYSA-N azane;2-methyl-2-(prop-2-enoylamino)propane-1-sulfonic acid Chemical compound [NH4+].[O-]S(=O)(=O)CC(C)(C)NC(=O)C=C BQMNFPBUAQPINY-UHFFFAOYSA-N 0.000 claims description 5
- 239000001768 carboxy methyl cellulose Substances 0.000 claims description 5
- 235000010948 carboxy methyl cellulose Nutrition 0.000 claims description 5
- 239000000679 carrageenan Substances 0.000 claims description 5
- 235000010418 carrageenan Nutrition 0.000 claims description 5
- 229920001525 carrageenan Polymers 0.000 claims description 5
- 229940113118 carrageenan Drugs 0.000 claims description 5
- 239000004359 castor oil Substances 0.000 claims description 5
- 235000019438 castor oil Nutrition 0.000 claims description 5
- 238000001816 cooling Methods 0.000 claims description 5
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 claims description 5
- 239000010487 meadowfoam seed oil Substances 0.000 claims description 5
- 239000004006 olive oil Substances 0.000 claims description 5
- 235000008390 olive oil Nutrition 0.000 claims description 5
- 235000020238 sunflower seed Nutrition 0.000 claims description 5
- LADGBHLMCUINGV-UHFFFAOYSA-N tricaprin Chemical compound CCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCC)COC(=O)CCCCCCCCC LADGBHLMCUINGV-UHFFFAOYSA-N 0.000 claims description 5
- 229920002554 vinyl polymer Polymers 0.000 claims description 5
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 claims description 5
- WSGCRSMLXFHGRM-DEVHWETNSA-N (2s)-2-[[(2s)-6-amino-2-[[(2s,3r)-2-[[(2s,3r)-2-[[(2s)-6-amino-2-(hexadecanoylamino)hexanoyl]amino]-3-hydroxybutanoyl]amino]-3-hydroxybutanoyl]amino]hexanoyl]amino]-3-hydroxypropanoic acid Chemical compound CCCCCCCCCCCCCCCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(O)=O WSGCRSMLXFHGRM-DEVHWETNSA-N 0.000 claims description 4
- 108010020346 Polyglutamic Acid Proteins 0.000 claims description 4
- QMIFIFIYYPUVNU-ACMTZBLWSA-L copper (2S)-6-amino-2-[[(2S)-2-[(2-aminoacetyl)amino]-3-imidazol-1-id-4-ylpropanoyl]amino]hexanoate Chemical compound [Cu+2].NCCCC[C@@H](C([O-])=O)NC(=O)[C@@H](NC(=O)CN)CC1=C[N-]C=N1 QMIFIFIYYPUVNU-ACMTZBLWSA-L 0.000 claims description 4
- 229920001495 poly(sodium acrylate) polymer Polymers 0.000 claims description 4
- 229920002643 polyglutamic acid Polymers 0.000 claims description 4
- NNMHYFLPFNGQFZ-UHFFFAOYSA-M sodium polyacrylate Chemical compound [Na+].[O-]C(=O)C=C NNMHYFLPFNGQFZ-UHFFFAOYSA-M 0.000 claims description 4
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 claims description 4
- GFEYWOGCSROPRT-OBXVVNIGSA-N (2s)-1-[(2s)-2-[[(2s)-1-[(2s)-2-[[(2s)-2-[[(2s)-2-amino-3-phenylpropanoyl]amino]-3-methylbutanoyl]amino]propanoyl]pyrrolidine-2-carbonyl]amino]-3-phenylpropanoyl]pyrrolidine-2-carboxylic acid Chemical compound C([C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N1[C@@H](CCC1)C(O)=O)C1=CC=CC=C1 GFEYWOGCSROPRT-OBXVVNIGSA-N 0.000 claims description 3
- QGGBBQJHVCVVKM-XOBYPWAZSA-N (4s)-4-acetamido-5-[[(2s)-1-[[(2s)-1-[[(2s)-5-amino-1-[[(2s)-1-[[(2s)-1-[[(2s)-1-[[(2s)-1-amino-3-carboxy-1-oxopropan-2-yl]amino]-1-oxopropan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amin Chemical compound OC(=O)CC[C@H](NC(C)=O)C(=C)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(O)=O)C(N)=O QGGBBQJHVCVVKM-XOBYPWAZSA-N 0.000 claims description 3
- 229940043375 1,5-pentanediol Drugs 0.000 claims description 3
- ABEXEQSGABRUHS-UHFFFAOYSA-N 16-methylheptadecyl 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCCOC(=O)CCCCCCCCCCCCCCC(C)C ABEXEQSGABRUHS-UHFFFAOYSA-N 0.000 claims description 3
- 229940043268 2,2,4,4,6,8,8-heptamethylnonane Drugs 0.000 claims description 3
- JPWUIQIFCDAWQX-UHFFFAOYSA-N 2,3-dihydroxypropyl 2-ethylhexanoate Chemical compound CCCCC(CC)C(=O)OCC(O)CO JPWUIQIFCDAWQX-UHFFFAOYSA-N 0.000 claims description 3
- ZFFMLCVRJBZUDZ-UHFFFAOYSA-N 2,3-dimethylbutane Chemical group CC(C)C(C)C ZFFMLCVRJBZUDZ-UHFFFAOYSA-N 0.000 claims description 3
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 claims description 3
- 229920000936 Agarose Polymers 0.000 claims description 3
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 claims description 3
- UMVMVEZHMZTUHD-UHFFFAOYSA-N DL-Propylene glycol dibenzoate Chemical compound C=1C=CC=CC=1C(=O)OC(C)COC(=O)C1=CC=CC=C1 UMVMVEZHMZTUHD-UHFFFAOYSA-N 0.000 claims description 3
- 229920002907 Guar gum Polymers 0.000 claims description 3
- 241000208467 Macadamia Species 0.000 claims description 3
- OQILCOQZDHPEAZ-UHFFFAOYSA-N Palmitinsaeure-octylester Natural products CCCCCCCCCCCCCCCC(=O)OCCCCCCCC OQILCOQZDHPEAZ-UHFFFAOYSA-N 0.000 claims description 3
- 108010047657 Phe-Val-Ala-Pro-Phe-Pro Proteins 0.000 claims description 3
- 229940078033 acetyl octapeptide-3 Drugs 0.000 claims description 3
- WNLRTRBMVRJNCN-UHFFFAOYSA-L adipate(2-) Chemical compound [O-]C(=O)CCCCC([O-])=O WNLRTRBMVRJNCN-UHFFFAOYSA-L 0.000 claims description 3
- 239000008163 avocado oil Substances 0.000 claims description 3
- 235000021302 avocado oil Nutrition 0.000 claims description 3
- 235000010290 biphenyl Nutrition 0.000 claims description 3
- 239000004305 biphenyl Substances 0.000 claims description 3
- 229960001777 castor oil Drugs 0.000 claims description 3
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 claims description 3
- 235000013399 edible fruits Nutrition 0.000 claims description 3
- 229920001971 elastomer Polymers 0.000 claims description 3
- 239000000806 elastomer Substances 0.000 claims description 3
- GJQLBGWSDGMZKM-UHFFFAOYSA-N ethylhexyl palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC(CC)CCCCC GJQLBGWSDGMZKM-UHFFFAOYSA-N 0.000 claims description 3
- 235000008524 evening primrose extract Nutrition 0.000 claims description 3
- 239000010475 evening primrose oil Substances 0.000 claims description 3
- 229940089020 evening primrose oil Drugs 0.000 claims description 3
- 239000000665 guar gum Substances 0.000 claims description 3
- 235000010417 guar gum Nutrition 0.000 claims description 3
- 229960002154 guar gum Drugs 0.000 claims description 3
- XJNUECKWDBNFJV-UHFFFAOYSA-N hexadecyl 2-ethylhexanoate Chemical compound CCCCCCCCCCCCCCCCOC(=O)C(CC)CCCC XJNUECKWDBNFJV-UHFFFAOYSA-N 0.000 claims description 3
- 229920006007 hydrogenated polyisobutylene Polymers 0.000 claims description 3
- KUVMKLCGXIYSNH-UHFFFAOYSA-N isopentadecane Natural products CCCCCCCCCCCCC(C)C KUVMKLCGXIYSNH-UHFFFAOYSA-N 0.000 claims description 3
- XUGNVMKQXJXZCD-UHFFFAOYSA-N isopropyl palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC(C)C XUGNVMKQXJXZCD-UHFFFAOYSA-N 0.000 claims description 3
- 229940060384 isostearyl isostearate Drugs 0.000 claims description 3
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 claims description 3
- WCVRQHFDJLLWFE-UHFFFAOYSA-N pentane-1,2-diol Chemical compound CCCC(O)CO WCVRQHFDJLLWFE-UHFFFAOYSA-N 0.000 claims description 3
- ZUOUZKKEUPVFJK-UHFFFAOYSA-N phenylbenzene Natural products C1=CC=CC=C1C1=CC=CC=C1 ZUOUZKKEUPVFJK-UHFFFAOYSA-N 0.000 claims description 3
- 229920003217 poly(methylsilsesquioxane) Polymers 0.000 claims description 3
- 229940062000 polyglyceryl-2 triisostearate Drugs 0.000 claims description 3
- 239000000600 sorbitol Substances 0.000 claims description 3
- 229940032094 squalane Drugs 0.000 claims description 3
- 239000000230 xanthan gum Substances 0.000 claims description 3
- 229920001285 xanthan gum Polymers 0.000 claims description 3
- 235000010493 xanthan gum Nutrition 0.000 claims description 3
- 229940082509 xanthan gum Drugs 0.000 claims description 3
- 229920001817 Agar Polymers 0.000 claims description 2
- 239000008272 agar Substances 0.000 claims description 2
- 125000006267 biphenyl group Chemical group 0.000 claims description 2
- 230000001804 emulsifying effect Effects 0.000 claims description 2
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims description 2
- 239000000126 substance Substances 0.000 claims description 2
- 241000097929 Porphyria Species 0.000 claims 1
- 208000010642 Porphyrias Diseases 0.000 claims 1
- 239000004816 latex Substances 0.000 claims 1
- 229920000126 latex Polymers 0.000 claims 1
- QMHBZWNZCSNBGU-UHFFFAOYSA-N nonane-1,2,3-triol Chemical compound CCCCCCC(O)C(O)CO QMHBZWNZCSNBGU-UHFFFAOYSA-N 0.000 claims 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 claims 1
- 208000002193 Pain Diseases 0.000 abstract description 8
- 239000013543 active substance Substances 0.000 abstract description 7
- 230000007794 irritation Effects 0.000 abstract description 6
- 210000003491 skin Anatomy 0.000 description 27
- 239000002585 base Substances 0.000 description 14
- 239000004615 ingredient Substances 0.000 description 11
- 238000010521 absorption reaction Methods 0.000 description 10
- 239000004480 active ingredient Substances 0.000 description 9
- 230000000052 comparative effect Effects 0.000 description 9
- 238000009472 formulation Methods 0.000 description 7
- 206010040880 Skin irritation Diseases 0.000 description 6
- 239000006071 cream Substances 0.000 description 6
- 239000006210 lotion Substances 0.000 description 6
- 230000008569 process Effects 0.000 description 6
- 231100000475 skin irritation Toxicity 0.000 description 6
- 230000036556 skin irritation Effects 0.000 description 6
- 230000000694 effects Effects 0.000 description 5
- 238000002360 preparation method Methods 0.000 description 5
- 239000002994 raw material Substances 0.000 description 5
- 206010015150 Erythema Diseases 0.000 description 4
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 4
- -1 acetyl hexamethylene Chemical group 0.000 description 4
- 230000003020 moisturizing effect Effects 0.000 description 4
- 206010061218 Inflammation Diseases 0.000 description 3
- 230000000844 anti-bacterial effect Effects 0.000 description 3
- 239000003963 antioxidant agent Substances 0.000 description 3
- 230000003078 antioxidant effect Effects 0.000 description 3
- 235000006708 antioxidants Nutrition 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 210000002615 epidermis Anatomy 0.000 description 3
- 231100000321 erythema Toxicity 0.000 description 3
- 239000000499 gel Substances 0.000 description 3
- 230000004054 inflammatory process Effects 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 235000013599 spices Nutrition 0.000 description 3
- MSWZFWKMSRAUBD-IVMDWMLBSA-N 2-amino-2-deoxy-D-glucopyranose Chemical compound N[C@H]1C(O)O[C@H](CO)[C@@H](O)[C@@H]1O MSWZFWKMSRAUBD-IVMDWMLBSA-N 0.000 description 2
- SHZGCJCMOBCMKK-UHFFFAOYSA-N D-mannomethylose Natural products CC1OC(O)C(O)C(O)C1O SHZGCJCMOBCMKK-UHFFFAOYSA-N 0.000 description 2
- SRBFZHDQGSBBOR-IOVATXLUSA-N D-xylopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- 239000004909 Moisturizer Substances 0.000 description 2
- VYGQUTWHTHXGQB-FFHKNEKCSA-N Retinol Palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C VYGQUTWHTHXGQB-FFHKNEKCSA-N 0.000 description 2
- OEWBEINAQKIQLZ-CMRBMDBWSA-N [(2s)-2-[(2r)-3,4-bis(2-hexyldecanoyloxy)-5-oxo-2h-furan-2-yl]-2-(2-hexyldecanoyloxy)ethyl] 2-hexyldecanoate Chemical compound CCCCCCCCC(CCCCCC)C(=O)OC[C@H](OC(=O)C(CCCCCC)CCCCCCCC)[C@H]1OC(=O)C(OC(=O)C(CCCCCC)CCCCCCCC)=C1OC(=O)C(CCCCCC)CCCCCCCC OEWBEINAQKIQLZ-CMRBMDBWSA-N 0.000 description 2
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 2
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 description 2
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 2
- MSWZFWKMSRAUBD-UHFFFAOYSA-N beta-D-galactosamine Natural products NC1C(O)OC(CO)C(O)C1O MSWZFWKMSRAUBD-UHFFFAOYSA-N 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000000839 emulsion Substances 0.000 description 2
- 239000000686 essence Substances 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 238000004108 freeze drying Methods 0.000 description 2
- 229960002442 glucosamine Drugs 0.000 description 2
- 238000007602 hot air drying Methods 0.000 description 2
- BJRNKVDFDLYUGJ-RMPHRYRLSA-N hydroquinone O-beta-D-glucopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-RMPHRYRLSA-N 0.000 description 2
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 2
- 229910021645 metal ion Inorganic materials 0.000 description 2
- 244000005700 microbiome Species 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 230000001333 moisturizer Effects 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- QIQXTHQIDYTFRH-UHFFFAOYSA-M octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC([O-])=O QIQXTHQIDYTFRH-UHFFFAOYSA-M 0.000 description 2
- 230000000149 penetrating effect Effects 0.000 description 2
- 229920000642 polymer Polymers 0.000 description 2
- 239000003755 preservative agent Substances 0.000 description 2
- 230000002335 preservative effect Effects 0.000 description 2
- 230000037384 skin absorption Effects 0.000 description 2
- 231100000274 skin absorption Toxicity 0.000 description 2
- 239000007921 spray Substances 0.000 description 2
- 230000037303 wrinkles Effects 0.000 description 2
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 description 1
- RGZSQWQPBWRIAQ-CABCVRRESA-N (-)-alpha-Bisabolol Chemical compound CC(C)=CCC[C@](C)(O)[C@H]1CCC(C)=CC1 RGZSQWQPBWRIAQ-CABCVRRESA-N 0.000 description 1
- 239000001500 (2R)-6-methyl-2-[(1R)-4-methyl-1-cyclohex-3-enyl]hept-5-en-2-ol Substances 0.000 description 1
- KMACPCJUCHVVGP-FNRPHRCSSA-N (4S)-4-acetamido-5-[[(2S)-1-[[(2S)-1-[[(2S)-5-amino-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-amino-3-carboxy-1-oxopropan-2-yl]amino]-1-oxopropan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-1,5-dioxopentan-2-yl]amino]-4-methylsulfanyl-1-oxobutan-2-yl]amino]-4-carboxy-1-oxobutan-2-yl]amino]-5-oxopentanoic acid Chemical compound OC(=O)CC[C@H](NC(C)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(O)=O)C(N)=O KMACPCJUCHVVGP-FNRPHRCSSA-N 0.000 description 1
- SERLAGPUMNYUCK-DCUALPFSSA-N 1-O-alpha-D-glucopyranosyl-D-mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O SERLAGPUMNYUCK-DCUALPFSSA-N 0.000 description 1
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- LFESLSYSZQYEIZ-UHFFFAOYSA-N 3-octanoyloxybutyl octanoate Chemical compound CCCCCCCC(=O)OCCC(C)OC(=O)CCCCCCC LFESLSYSZQYEIZ-UHFFFAOYSA-N 0.000 description 1
- AJBZENLMTKDAEK-UHFFFAOYSA-N 3a,5a,5b,8,8,11a-hexamethyl-1-prop-1-en-2-yl-1,2,3,4,5,6,7,7a,9,10,11,11b,12,13,13a,13b-hexadecahydrocyclopenta[a]chrysene-4,9-diol Chemical compound CC12CCC(O)C(C)(C)C1CCC(C1(C)CC3O)(C)C2CCC1C1C3(C)CCC1C(=C)C AJBZENLMTKDAEK-UHFFFAOYSA-N 0.000 description 1
- 235000003880 Calendula Nutrition 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- AEMOLEFTQBMNLQ-AQKNRBDQSA-N D-glucopyranuronic acid Chemical compound OC1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O AEMOLEFTQBMNLQ-AQKNRBDQSA-N 0.000 description 1
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- 206010013786 Dry skin Diseases 0.000 description 1
- 235000009414 Elaeocarpus kirtonii Nutrition 0.000 description 1
- 239000004386 Erythritol Substances 0.000 description 1
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 description 1
- PNNNRSAQSRJVSB-SLPGGIOYSA-N Fucose Natural products C[C@H](O)[C@@H](O)[C@H](O)[C@H](O)C=O PNNNRSAQSRJVSB-SLPGGIOYSA-N 0.000 description 1
- IAJILQKETJEXLJ-UHFFFAOYSA-N Galacturonsaeure Natural products O=CC(O)C(O)C(O)C(O)C(O)=O IAJILQKETJEXLJ-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 239000004378 Glycyrrhizin Substances 0.000 description 1
- SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 description 1
- MLSJBGYKDYSOAE-DCWMUDTNSA-N L-Ascorbic acid-2-glucoside Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O[C@@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)=C1O MLSJBGYKDYSOAE-DCWMUDTNSA-N 0.000 description 1
- SHZGCJCMOBCMKK-DHVFOXMCSA-N L-fucopyranose Chemical compound C[C@@H]1OC(O)[C@@H](O)[C@H](O)[C@@H]1O SHZGCJCMOBCMKK-DHVFOXMCSA-N 0.000 description 1
- SHZGCJCMOBCMKK-JFNONXLTSA-N L-rhamnopyranose Chemical compound C[C@@H]1OC(O)[C@H](O)[C@H](O)[C@H]1O SHZGCJCMOBCMKK-JFNONXLTSA-N 0.000 description 1
- PNNNRSAQSRJVSB-UHFFFAOYSA-N L-rhamnose Natural products CC(O)C(O)C(O)C(O)C=O PNNNRSAQSRJVSB-UHFFFAOYSA-N 0.000 description 1
- DUKURNFHYQXCJG-UHFFFAOYSA-N Lewis A pentasaccharide Natural products OC1C(O)C(O)C(C)OC1OC1C(OC2C(C(O)C(O)C(CO)O2)O)C(NC(C)=O)C(OC2C(C(OC3C(OC(O)C(O)C3O)CO)OC(CO)C2O)O)OC1CO DUKURNFHYQXCJG-UHFFFAOYSA-N 0.000 description 1
- 239000005913 Maltodextrin Substances 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- OVRNDRQMDRJTHS-FMDGEEDCSA-N N-acetyl-beta-D-glucosamine Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O OVRNDRQMDRJTHS-FMDGEEDCSA-N 0.000 description 1
- 241001483078 Phyto Species 0.000 description 1
- 241001092459 Rubus Species 0.000 description 1
- 244000181917 Rubus leucodermis Species 0.000 description 1
- 235000011036 Rubus leucodermis Nutrition 0.000 description 1
- 206010040844 Skin exfoliation Diseases 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- 244000236151 Tabebuia pallida Species 0.000 description 1
- 235000013584 Tabebuia pallida Nutrition 0.000 description 1
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 description 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 238000005054 agglomeration Methods 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 description 1
- RGZSQWQPBWRIAQ-LSDHHAIUSA-N alpha-Bisabolol Natural products CC(C)=CCC[C@@](C)(O)[C@@H]1CCC(C)=CC1 RGZSQWQPBWRIAQ-LSDHHAIUSA-N 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000003266 anti-allergic effect Effects 0.000 description 1
- PYMYPHUHKUWMLA-WDCZJNDASA-N arabinose Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)C=O PYMYPHUHKUWMLA-WDCZJNDASA-N 0.000 description 1
- 229960000271 arbutin Drugs 0.000 description 1
- 229940067599 ascorbyl glucoside Drugs 0.000 description 1
- 125000003289 ascorbyl group Chemical group [H]O[C@@]([H])(C([H])([H])O*)[C@@]1([H])OC(=O)C(O*)=C1O* 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 229940114374 butylene glycol dicaprylate Drugs 0.000 description 1
- 229940059958 centella asiatica extract Drugs 0.000 description 1
- 239000003240 coconut oil Substances 0.000 description 1
- 235000019864 coconut oil Nutrition 0.000 description 1
- 238000007906 compression Methods 0.000 description 1
- 230000006835 compression Effects 0.000 description 1
- 230000003750 conditioning effect Effects 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 1
- 230000001877 deodorizing effect Effects 0.000 description 1
- 210000004207 dermis Anatomy 0.000 description 1
- 239000003599 detergent Substances 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- GPLRAVKSCUXZTP-UHFFFAOYSA-N diglycerol Chemical compound OCC(O)COCC(O)CO GPLRAVKSCUXZTP-UHFFFAOYSA-N 0.000 description 1
- 239000000539 dimer Substances 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 230000037336 dry skin Effects 0.000 description 1
- 238000001962 electrophoresis Methods 0.000 description 1
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 description 1
- 235000019414 erythritol Nutrition 0.000 description 1
- 229940009714 erythritol Drugs 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 230000001815 facial effect Effects 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 229940097043 glucuronic acid Drugs 0.000 description 1
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 description 1
- 229960004949 glycyrrhizic acid Drugs 0.000 description 1
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 description 1
- 235000019410 glycyrrhizin Nutrition 0.000 description 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 1
- 229920000591 gum Polymers 0.000 description 1
- 239000003906 humectant Substances 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 description 1
- 229960000367 inositol Drugs 0.000 description 1
- 239000000905 isomalt Substances 0.000 description 1
- 235000010439 isomalt Nutrition 0.000 description 1
- HPIGCVXMBGOWTF-UHFFFAOYSA-N isomaltol Natural products CC(=O)C=1OC=CC=1O HPIGCVXMBGOWTF-UHFFFAOYSA-N 0.000 description 1
- 230000005722 itchiness Effects 0.000 description 1
- 229930188348 kazinol Natural products 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 229940078752 magnesium ascorbyl phosphate Drugs 0.000 description 1
- 229940035034 maltodextrin Drugs 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 238000003701 mechanical milling Methods 0.000 description 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
- 239000011259 mixed solution Substances 0.000 description 1
- 229950006780 n-acetylglucosamine Drugs 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 150000002894 organic compounds Chemical class 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- BJRNKVDFDLYUGJ-UHFFFAOYSA-N p-hydroxyphenyl beta-D-alloside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-UHFFFAOYSA-N 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 238000010298 pulverizing process Methods 0.000 description 1
- 230000001172 regenerating effect Effects 0.000 description 1
- 229940100552 retinamide Drugs 0.000 description 1
- 239000011607 retinol Substances 0.000 description 1
- 229960003471 retinol Drugs 0.000 description 1
- 235000020944 retinol Nutrition 0.000 description 1
- 239000011769 retinyl palmitate Substances 0.000 description 1
- 229940108325 retinyl palmitate Drugs 0.000 description 1
- 235000019172 retinyl palmitate Nutrition 0.000 description 1
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 description 1
- 210000002374 sebum Anatomy 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 230000009759 skin aging Effects 0.000 description 1
- 230000008591 skin barrier function Effects 0.000 description 1
- 230000036560 skin regeneration Effects 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 238000000859 sublimation Methods 0.000 description 1
- 230000008022 sublimation Effects 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 230000000475 sunscreen effect Effects 0.000 description 1
- 239000000516 sunscreening agent Substances 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 229960001295 tocopherol Drugs 0.000 description 1
- 229930003799 tocopherol Natural products 0.000 description 1
- 235000010384 tocopherol Nutrition 0.000 description 1
- 239000011732 tocopherol Substances 0.000 description 1
- 229940074410 trehalose Drugs 0.000 description 1
- HTJNEBVCZXHBNJ-XCTPRCOBSA-H trimagnesium;(2r)-2-[(1s)-1,2-dihydroxyethyl]-3,4-dihydroxy-2h-furan-5-one;diphosphate Chemical compound [Mg+2].[Mg+2].[Mg+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.OC[C@H](O)[C@H]1OC(=O)C(O)=C1O HTJNEBVCZXHBNJ-XCTPRCOBSA-H 0.000 description 1
- 229930182493 triterpene saponin Natural products 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 230000002087 whitening effect Effects 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/60—Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
- A61K8/89—Polysiloxanes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
Definitions
- the present invention relates to cosmetic compositions and methods for producing the same. More specifically, it relates to a cosmetic composition containing microstructures and a method for producing the same.
- the active agent can be easily absorbed without hindering absorption by the epidermis layer of the skin.
- the microstructure contains a biodegradable material, as the microneedles included in the microstructure gradually decompose, the active agent is slowly leaked out, so that it can be continuously absorbed. Accordingly, side effects caused by injecting an excessive amount of the active agent at once can be effectively prevented.
- Micro structures can be applied, for example, with rollers, patches, stamps, etc.
- rollers, patches, stamps, etc. there is a problem that skin irritation or pain occurs during the process of directly penetrating and absorbing the microstructure into the skin.
- the purpose of the present invention is to provide a cosmetic composition containing microstructures.
- the purpose of the present invention is to provide a method for producing a cosmetic composition containing microstructures.
- the cosmetic composition according to an exemplary embodiment includes 0.1 to 30% by weight of microstructure, 50 to 90% by weight of hydrocarbon-based oil, 5 to 25% by weight of silicone powder, 0.001 to 0.1% by weight of vegetable oil, and 0.1 to 1% by weight of fragrance, based on the total weight of the composition. It may include weight percent.
- the cosmetic composition according to an exemplary embodiment includes 0.1 to 30% by weight of microstructure, 70 to 90% by weight of purified water, 5 to 20% by weight of polyhydric alcohol, 0.1 to 1% by weight of high molecular weight polymer, and 0.001 to 1% by weight of functional peptide, based on the total weight of the composition.
- % vegetable oil 0.1 to 2% by weight, polysaccharide 0.01 to 0.5% by weight, phenoxyethanol 0.05 to 1% by weight, hyaluronic acid 0.1 to 1% by weight, niacinamide 1 to 10% by weight, white-throated mushroom sporangia extract 0.01 to 10%.
- berry extract 0.1 to 1% by weight adenosine 0.01 to 0.1% by weight, and fragrance 0.005 to 0.1% by weight. % may be included.
- the microstructure may include a microneedle structure that dissolves within the skin.
- the microstructure may have an average length of 10 to 1,000 ⁇ m and an average diameter of 10 to 1,000 ⁇ m.
- the microstructure contains 40 to 70% by weight of sodium hyaluronate, 10 to 30% by weight of lactose, 10 to 30% by weight of glycerin, 0.1 to 5% by weight of madecassoside, and acetyl hexamethylene based on the total weight of the structure.
- Peptide 0.001 to 0.1% by weight, licorice root extract 0.001 to 0.1% by weight, port marigold flower extract 0.0001 to 0.1% by weight, caprylyl glycol 0.01 to 0.1% by weight, propanediol 1 to 10% by weight, ethylhexylglycerin It may contain 0.1 to 1% by weight and 0.001 to 0.1% by weight of 1,2-hexanediol.
- the hydrocarbon-based oil is caprylic/capric triglyceride, triethylhexanoin, octyldodecanol, hydrogenated polyisobutene, cetyl ethyl hexanoate, butylene glycol dica.
- Prilate/Dicaprate Isopropyl Myristate, Polyglyceryl-2 Triisostearate, Glyceryl Ethylhexanoate/Stearate/Adipate, Ethylhexyl Palmitate, Isostearyl Isostearate, Diisopropyl It may include at least one selected from the group consisting of dimer dilinoleate, propylene glycol dibenzoate, isopropyl palmitate, and isohexadecane.
- the silicone powder is silica, silica dimethyl silylate, polymethylsilsesquioxane, vinyl dimethicone/methicone silsesquioxane crosspolymer, elastomer, dimethicone/dimethicone crosspolymer, dimethicone At least one selected from the group consisting of phenyldimethicone/vinyldiphenyldimethicone/silsesquioxane crosspolymer, dimethicone/vinyldimethicone crosspolymer, polysilicon-1 crosspolymer, polysilicon-11, and polysilicon-22. may include.
- the polyhydric alcohol is dipropylene glycol, glycerin, propylene glycol, butylene glycol, pentylene glycol, 1,2-hexanediol, caprylyl glycol, and ethylhexylglycerin. , and may include at least one selected from the group consisting of sorbitol.
- the high molecular weight polymer may include at least one selected from the group consisting of sodium polyacrylate, polyglutamic acid, PVM/MA copolymer, and ammonium acrylodimethyl taurate/VP copolymer. there is.
- the functional peptide is at least selected from the group consisting of hexapeptide-9, hexapeptide-11, acetyl hexapeptide-8, acetyl octapeptide-3, palmitoyl pentapeptide-4, and copper tripeptide-1. It can contain one.
- the polysaccharide may include at least one selected from the group consisting of carrageenan, agarose, cellulose gum, xanthan gum, arabica gum, and guar gum.
- the vegetable oil is at least one selected from the group consisting of jojoba seed oil, meadowfoam seed oil, sunflower seed oil, olive oil, argan kernel oil, avocado oil, macadamia seed oil, evening primrose oil, squalane, and castor oil. It can contain one.
- a method of manufacturing a cosmetic composition includes preparing a microstructure; Preparing a microstructure mixture by mixing the microstructure, silicon powder, and fragrance; Emulsifying the microstructure mixture by mixing it with oil; And it may include cooling and defoaming.
- a method of manufacturing a cosmetic composition according to an exemplary embodiment includes preparing a microstructure; Preparing an aqueous base solvent; And it may include mixing the base solvent and the aqueous base solvent to prepare a mixed microstructure solution.
- preparing the microstructure includes forming a preliminary microstructure by putting a composition for forming a microstructure into a mold and compressing it; Drying the preliminary microstructure; Separating the dried preliminary microstructure from the mold; And it may include the step of crushing the dried and separated preliminary microstructure to form a microstructure.
- the composition for forming microstructures includes 40 to 70% by weight of sodium hyaluronate, 10 to 30% by weight of lactose, 10 to 30% by weight of glycerin, 0.1 to 5% by weight of madecassoside, and acetylhexapeptide.
- 0.001 to 0.1% by weight licorice root extract 0.001 to 0.1% by weight, port marigold flower extract 0.0001 to 0.1% by weight, caprylyl glycol 0.01 to 0.1% by weight, propanediol 1 to 10% by weight, ethylhexylglycerin 0.1 to 1% by weight and may include 0.001 to 0.1% by weight of 1,2-hexanediol.
- the micro structure mixture may have a mixing ratio of silicon powder to the micro structures of 1 to 5, and a mixing ratio of the fragrance to the micro structures may be 1/10 to 1/20.
- the mixing ratio of the oil to the microstructure mixture may be 3 to 5.
- the aqueous base solvent is 70 to 90% by weight of purified water, 5 to 20% by weight of polyhydric alcohol, 0.1 to 1% by weight of high molecular weight polymer, 0.05 to 1% by weight of phenoxyethanol, and 0.1 to 1% by weight of hyaluronic acid.
- % functional peptide 0.001 to 1% by weight, niacinamide 1 to 10% by weight, white wood ear mushroom sporangia fruit extract 0.01 to 1% by weight, berry extract 0.1 to 1% by weight, licorice extract 0.001 to 0.1% by weight, port marigold flower It may include 0.0005 to 0.5% by weight of extract, 0.1 to 2% by weight of vegetable oil, 0.1 to 2% by weight of panthenol, 0.01 to 0.1% by weight of adenosine, 0.01 to 0.5% by weight of polysaccharide, and 0.005 to 0.1% by weight of fragrance.
- the weight ratio of the microstructure to the weight of the aqueous base solvent may be 0.1 to 1.
- the cosmetic composition containing the microstructure of the present invention can be applied to the skin to quickly inject the active agent into the skin without pain or irritation.
- the method for producing a cosmetic composition containing the microstructure of the present invention can simplify the process and can be easily mass-produced.
- Figure 1 is an example of a method for manufacturing a microstructure.
- Figures 2 and 3 each show examples of a method for manufacturing a cosmetic composition containing microstructures.
- the present invention provides a cosmetic composition containing microstructures and a method for producing the same.
- the microstructure according to one embodiment contains 40 to 70% by weight of sodium hyaluronate, 10 to 30% by weight of lactose, 10 to 30% by weight of glycerin, 0.1 to 5% by weight of madecassoside, and 0.001% by weight of acetyl hexapeptide, based on the total weight of the structure. to 0.1% by weight, licorice root extract 0.001 to 0.1% by weight, port marigold flower extract 0.0001 to 0.1% by weight, caprylyl glycol 0.01 to 0.1% by weight, propanediol 1 to 10% by weight, ethylhexylglycerin 0.1 to 0.1%. It may contain 1% by weight and 0.001 to 0.1% by weight of 1,2-hexanediol. If necessary, additional water may be added.
- Sodium hyaluronate also called hyaluronic acid, has skin moisturizing and skin conditioning effects when used in cosmetic compositions.
- sodium hyaluronate may be included in an amount of 40 to 70% by weight, 45 to 65% by weight, or 50 to 60% by weight based on the total weight of the microstructure.
- the molecular weight of sodium hyaluronate is not limited to this, but is preferably 1,000 to 5,000,000 (kDa) in order to realize various physical properties and biocompatibility.
- Lactose may be included as a sugar component to increase mechanical strength with sodium hyaluronate. Lactose may be included in an amount of 10 to 30% by weight, 10 to 25% by weight, and 12 to 20% by weight based on the total weight of the microstructure. However, it is not limited thereto, but for example, Dextrin, Malto-dextrin, Xylose, Sucrose, Maltose, Glucose, Glucosamine ( Glucosamine, Glucuronic acid, Rhamnose, Mannose, Fucose, Arabinose, Acetylglucosamine, Inositol, Trehalose, Isomalt, Xylitol, and Erythritol may be used. Additionally, sugar components can be used as excipients.
- Glycerin is a type of polyhydric alcohol and can be added to control dispersion and viscosity.
- Ethylhexylglycerin is a glyceryl ether, an organic compound, and a type of glycerin. It provides antibacterial and deodorizing effects, and can also act as a humectant or solvent. It may contain 10 to 30% by weight, 10 to 25% by weight, and 12 to 20% by weight based on the total weight of the microstructure.
- Ethylhexylglycerin may be included in an amount of 0.1 to 1% by weight, for example, 0.1 to 0.5% by weight.
- Madecassoside is an ingredient extracted from Centella asiatica extract and is effective in improving inflammation and has a skin regenerative effect. In addition, it is effective in controlling oil and water balance by controlling excessive sebum secretion. It is also effective in improving itchiness caused by dry skin. Madecassoside may be included in an amount of 0.1 to 5% by weight, 0.1 to 3% by weight, for example, 0.1 to 1% by weight, based on the total weight of the microstructure.
- Acetyl hexapeptide is an active ingredient for improving wrinkles.
- acetylhexapeptide-8 can be used. It may be included in an amount of 0.001 to 0.1% by weight or 0.001 to 0.05% by weight based on the total weight of the structure.
- Licorice root extract contains glycyrrhizin, a triterpene saponin, as an active ingredient and has antibacterial, anti-allergic, and antioxidant physiological activities. It may be included in an amount of 0.001 to 0.1% by weight or 0.001 to 0.05% by weight based on the total weight of the structure.
- the flavonoids in port marigold flower extract the main component of calendula, have strong antioxidant and soothing effects. Therefore, it suppresses inflammation and has excellent skin regeneration effects. It may be included in an amount of 0.0001 to 0.1% by weight or 0.0001 to 0.01% by weight based on the total weight of the structure.
- Caprylyl Glycol is an ingredient mainly extracted from coconut oil and can be used as a skin moisturizer and skin softener. Additionally, it has an antibacterial effect and can be used as a natural preservative. It may be included in an amount of 0.01 to 0.1% by weight, 0.01 to 0.08% by weight, and 0.001 to 0.05% by weight based on the total weight of the structure.
- Propanediol is a natural ingredient extracted by fermentation from corn and can be used as a moisturizer, solvent, viscosity regulator, and preservative. It is also effective in preventing skin aging due to its tocopherol content. Based on the total weight of the structure, propanediol may be included in an amount of 1 to 10% by weight and 2 to 9% by weight.
- 1,2-hexanediol provides excellent moisturizing and nutritional properties and has excellent stability even under wide pH conditions and high temperature processes. It may be included in an amount of 0.001 to 0.1% by weight or 0.002 to 0.05% by weight based on the total weight of the structure.
- Figure 1 schematically shows a method of manufacturing a microstructure according to an embodiment.
- a composition for forming microstructures can be prepared (for example, S-111).
- a composition for forming microstructures may be prepared with the above-mentioned ingredients and contents. If necessary, extra water may be included.
- composition for forming the micro structure may be placed in a mold and compressed to form a preliminary micro structure (for example, S-112).
- compression may be performed by applying 1.5 to 5 tons of pressure for 5 to 300 seconds.
- the prepared preliminary microstructure can be dried and separated from the mold (e.g., S-113). For example, drying can be done with hot air at 20°C to 70°C for 15 to 90 minutes. During the drying process, solvents, water, etc. contained in the preliminary microstructure may evaporate.
- drying may be freeze-drying.
- the prepared preliminary microstructure can be frozen at a temperature of -10°C to -30°C and left under reduced pressure to remove moisture in the sample by sublimation.
- drying may be hot air drying and freeze drying.
- moisture may be additionally removed by freezing at a temperature of -10°C to -30°C and leaving under reduced pressure.
- the dried preliminary microstructure can be crushed or pulverized into an appropriate size or shape to form a microstructure (for example, S-114).
- the formed microstructure can be used as a raw material for cosmetic compositions.
- crushing or pulverizing can be done by mechanical milling of microstructures, such as roll-mill, ball-mill, hammer-mill, high energy ball mill, or planetary mill.
- a planetary mill, stirred ball mill, vibrating mill, or jet-mill can be used.
- the cosmetic composition according to an exemplary embodiment may be, for example, an oil gel-type cosmetic composition.
- the oil gel type composition contains 0.1 to 30% by weight of microstructure, 50 to 90% by weight of hydrocarbon oil, 0.001 to 0.1% by weight of vegetable oil, 5 to 25% by weight of silicone powder, and 0.1 to 1% by weight of fragrance based on the total weight of the composition. It can be included.
- the microstructure may be included in an amount of 0.1 to 30% by weight. Preferably it may be contained in 1 to 25% by weight, more preferably in 5 to 20% by weight.
- the microstructure When applied to the skin in the above range, the microstructure can be absorbed without skin pain or irritation, and the absorption rate can also be improved. Additionally, the shape of the microstructure can also provide a skin peeling effect.
- the microstructure may include soluble microneedle structures that dissolve within the skin.
- dissolvable microneedles can be composed of a support portion and a drug portion. The drug portion dissolves within the skin and may dissolve or disintegrate when the microneedle is applied to the skin.
- dissolvable microneedles may be cone-shaped, jar-shaped, or horn-shaped polyhedrons with a base of a polygonal structure consisting of three or more sides.
- soluble microneedles may have an average length of 10 to 1,000 ⁇ m.
- the average diameter of soluble microneedles may be 10 to 1,000 ⁇ m.
- the diameter can fulfill all the functions of cosmetics.
- hydrocarbon-based oil may be included in an amount of 50 to 90% by weight. Preferably it may contain 55 to 85% by weight, more preferably 60 to 85% by weight. Within the above range, it can have an excellent skin moisturizing effect and act as a softener, and can also act as a solvent.
- the hydrocarbon-based oil includes caprylic/capric triglyceride, triethylhexanoin, octyldodecanol, hydrogenated polyisobutene, cetyl ethyl hexanoate, butylene glycol dicaprylate.
- Isopropyl Myristate Polyglyceryl-2 Triisostearate, Glyceryl Ethylhexanoate/Stearate/Adipate, Ethylhexyl Palmitate, Isostearyl Isostearate, Diisopropyl Dimerda It may be irisoleate, propylene glycol dibenzoate, isopropyl palmitate, isohexadecane, or mixtures thereof.
- vegetable oil may be included in an amount of 0.001 to 0.1% by weight. Preferably, it may contain 0.001 to 0.08% by weight, more preferably 0.003 to 0.06% by weight. Within the above range, various unsaturated fat-soluble active ingredients necessary for skin improvement can be provided.
- the vegetable oil may be jojoba seed oil, meadowfoam seed oil, sunflower seed oil, olive oil, argan kernel oil, avocado oil, macadamia seed oil, evening primrose oil, squalane, castor oil, or mixtures thereof.
- silicone powder may contain 5 to 25% by weight of silicone powder based on the total weight of the composition. Preferably it may be contained in 5 to 20% by weight, more preferably in 10 to 15% by weight. Within the above range, excellent water absorption and oil absorption can be provided.
- the silicone powder may include silica, silica dimethyl silylate, polymethyl silsesquioxane, vinyl dimethicone/methicone silsesquioxane crosspolymer, elastomer, dimethicone/dimethicone crosspolymer, and diphenyl dimethicone. It may be chicone/vinyl diphenyl dimethicone/silsesquioxane crosspolymer, dimethicone/vinyl dimethicone crosspolymer, polysilicon-1 crosspolymer, polysilicon-11, polysilicon-22, or a mixture thereof.
- fragrance may contain 0.1 to 1% by weight of fragrance, preferably 0.1 to 0.8% by weight, based on the total weight of the composition.
- fragrance there is no particular limitation as long as the fragrance within the above range is commonly used in cosmetic compositions.
- the cosmetic composition according to an exemplary embodiment may be, for example, an aqueous type cosmetic composition.
- the aqueous type composition contains 0.1 to 30% by weight of microstructure, 70 to 90% by weight of purified water, 5 to 20% by weight of polyhydric alcohol, 0.1 to 1% by weight of high molecular weight polymer, and 0.001 to 1% by weight of functional peptide based on the total weight of the composition.
- % vegetable oil 0.1 to 2% by weight, polysaccharide 0.01 to 0.5% by weight, phenoxyethanol 0.05 to 1% by weight, hyaluronic acid 0.1 to 1% by weight, niacinamide 1 to 10% by weight, white-throated mushroom sporangia extract 0.01 to 10%.
- berry extract 0.1 to 1% by weight adenosine 0.01 to 0.1% by weight, and fragrance 0.005 to 0.1% by weight. % may be included.
- purified water may be included in an amount of 70 to 90% by weight, preferably 80 to 90% by weight.
- Purified water may be, for example, general purified water or ultrapure purified water.
- General purified water is water commonly used in pharmaceuticals, cosmetics, etc., and has a dissolved solids content of 1.0 to 0.5 ppm, indicating purity, a filter size of 0.2 to 0.45 ⁇ m used to remove particulates and microorganisms when producing purified water, and a pH of 0.2 to 0.45 ⁇ m. It may be a weak acid or a weak alkali.
- Ultrapure purified water has a very high purity with a dissolved solid content of 0.03ppm, and the size of the filter used to produce ultrapure purified water is 0.001 ⁇ m, which removes 99.99% of microorganisms.
- ultrapure purified water not only prevents the auto-oxidation reaction of the composition by removing metal ions, but also prevents polymer agglomeration caused by metal ions, allowing the formulation to be applied evenly while being mild.
- the polyhydric alcohol may be included in an amount of 5 to 20% by weight, preferably 10 to 20% by weight.
- Polyhydric alcohol is a solvent containing two or more hydroxy groups, for example, dipropylene glycol, glycerin, propylene glycol, butylene glycol, pentylene glycol, 1,2-hexanediol, capryl. It may be lyl glycol, ethylhexylglycerin, or sorbitol or a mixture thereof.
- the polymer may be included in an amount of 0.1 to 1% by weight, preferably 0.2 to 0.8% by weight. This can increase the viscosity of the composition and help stabilize the formulation.
- the high molecular weight polymer may be, for example, sodium polyacrylate, polyglutamic acid, PVM/MA copolymer, ammonium acrylodimethyltaurate/VP copolymer.
- the functional peptide may be 0.001 to 1% by weight, preferably 0.001 to 0.01% by weight. As a result, it can provide antioxidant and skin anti-aging effects.
- the functional peptide may be, for example, hexapeptide-9, hexapeptide-11, acetyl hexapeptide-8, acetyl octapeptide-3, palmitoyl pentapeptide-4 or copper tripeptide-1.
- polysaccharides may be included in an amount of 0.01 to 0.5% by weight, preferably 0.01 to 0.1% by weight. Accordingly, it is possible to provide a cosmetic composition with excellent spreadability and excellent absorption.
- Polysaccharides may be, for example, carrageenan, agar and agarose, cellulose gum, xanthan gum, gum arabica, guar gum.
- phenoxyethanol may be included in an amount of 0.05 to 1% by weight, preferably 0.1 to 0.5% by weight
- hyaluronic acid may be included in an amount of 0.1 to 1% by weight, preferably 0.1 to 0.5% by weight.
- niacinamide may be included in an amount of 1 to 10% by weight, preferably 1 to 5% by weight
- panthenol may be included in an amount of 0.1 to 2% by weight, preferably 0.1 to 1% by weight
- adenosine may be included in an amount of 0.01 to 1% by weight. It may be included at 0.1% by weight, preferably at 0.01 to 0.05% by weight.
- the extract based on the total weight of the composition, it may include 0.01 to 1% by weight of White-eared mushroom sporangia fruit extract, 0.1 to 1% by weight of berry extract, 0.001 to 0.1% by weight of licorice extract, and 0.0005 to 0.5% by weight of port marigold flower extract. and is not limited thereto.
- Cosmetic compositions according to some embodiments may further include other active ingredients known in the art for use in cosmetics in addition to the ingredients listed above.
- kazinol, arbutin, ethyl ascorbyl ether, ascorbyl glucoside, Magnesium Ascorbyl Phosphate, ascorbyl tetraisopalmitate It may be ascorbyl tetraisopalmitate, alpha-bisabolol, retinol, retinyl palmitate, polyethoxylated retinamide and derivatives thereof, but in addition to this, sugar
- active ingredients can be used in the field to improve efficacy such as improving skin condition, improving wrinkles, improving inflammation, moisturizing, whitening, blocking ultraviolet rays, and improving skin barrier function.
- the other active ingredients may be included, for example, at 0.1 to 10% by weight, 0.1 to 8% by weight, 0.1 to 5% by weight, 0.1 to 3% by weight, and 0.1 to 1% by weight based on the total weight of the composition, but are limited thereto. no.
- Figure 2 schematically shows an example of a method for manufacturing a cosmetic composition containing microstructures.
- a microstructure e.g., S-100
- the raw materials included in each step may be, for example, raw materials for an oil gel-type cosmetic composition. Specific details of the microstructure, silicone powder, fragrance, and oil are the same as described above.
- the microstructure may be mixed with silicon powder and fragrance to form a microstructure mixture (for example, S-200). Mixing can be performed for example.
- the mixing ratio of silicon powder to microstructure may be 1 to 5, preferably 1 to 3.
- the mixing ratio of the fragrance to the micro structure may be 1/10 to 1/20, and preferably 1/10 to 1/15.
- the microstructure mixture can be emulsified by mixing it with oil (e.g., S-300).
- oil e.g., S-300
- the mixing ratio of oil to the microstructure mixture may be 3 to 5.
- the oil may include vegetable oil and hydrocarbon-based oil, and the hydrocarbon-based oil may preferably be caprylic/capric triglyceride, triethylhexanoin, octyldodecanol, or mixtures thereof.
- the vegetable oil may preferably be jojoba seed oil, meadowfoam seed oil, sunflower seed oil, olive oil, argan kernel oil, or a mixture thereof.
- the mixture can be mixed by raising the temperature to 60 to 80°C and passing it through a high-pressure homogenizer.
- a cosmetic composition containing microstructures can be obtained through a cooling and defoaming process (for example, S-400). Cooling is carried out at 30 to 45°C and then defoamed to finally obtain a cosmetic composition.
- a cooling and defoaming process for example, S-400. Cooling is carried out at 30 to 45°C and then defoamed to finally obtain a cosmetic composition.
- Figure 3 schematically shows another example of a method for manufacturing a cosmetic composition containing microstructures.
- the raw materials included in each step may be, for example, raw materials for an aqueous type cosmetic composition.
- microstructure e.g., S-110.
- S-110 a microstructure
- the specific details of the micro structure are the same as described above.
- an aqueous base solvent (e.g., S-120).
- the aqueous base solvent is 70 to 90% by weight of purified water, 5 to 20% by weight of polyhydric alcohol, 0.1 to 1% by weight of high molecular weight polymer, 0.05 to 1% by weight of phenoxyethanol, 0.1 to 1% by weight of hyaluronic acid, and 0.001 to 1% by weight of functional peptide.
- niacinamide 1 to 10% by weight white-throated mushroom sporangia extract 0.01 to 1% by weight, berry extract 0.1 to 1% by weight, licorice extract 0.001 to 0.1% by weight, port marigold flower extract 0.0005 to 0.5% by weight, vegetable It may include 0.1 to 2% by weight of oil, 0.1 to 2% by weight of panthenol, 0.01 to 0.1% by weight of adenosine, 0.01 to 0.1% by weight of polysaccharide, and 0.005 to 0.1% by weight of fragrance.
- the base solvent and the water-based base solvent can be mixed to prepare a microstructure mixed solution (for example, S-130).
- a microstructure mixed solution for example, S-130.
- Mixing can be carried out at room temperature.
- the weight ratio of the microstructure to the weight of the aqueous base solvent may be 0.1 to 1, preferably 0.1 to 0.5, and more preferably 0.1 to 0.3.
- Micro structures according to some embodiments do not require additional processes for application to patches, rollers, stamps, etc., and can be manufactured by simply adding the micro structures to a cosmetic composition. Therefore, the process can be simplified and mass production is easy.
- the formulation of the cosmetic composition may be in the form of a general emulsified formulation or solubilized formulation.
- lotion such as flexible lotion or nourishing lotion, emulsion such as facial lotion and oil, cream such as nutritional cream, moisture cream, eye cream, essence, cosmetic ointment, spray, oil gel, pack, sunscreen, makeup base, liquid
- cream such as nutritional cream, moisture cream, eye cream, essence, cosmetic ointment, spray, oil gel, pack, sunscreen, makeup base, liquid
- It can have formulations such as foundation type, solid type or spray type, makeup remover such as powder, cleansing cream, cleansing lotion, cleansing oil, cleansing foam, soap, body wash, etc.
- the content of active ingredients in cosmetic compositions may vary depending on formulation and purpose. For example, a relatively high concentration is desirable for wash-off type cosmetics such as makeup removers and detergents, in which the active ingredients stay on the skin for a short period of time.
- wash-off type cosmetics such as makeup removers and detergents
- leave-on type cosmetics such as lotion, emulsion, oil gel, cream, and essence, whose active ingredients stay on the skin for a long period of time, preferably have a relatively low concentration compared to wash-off type cosmetics.
- a microstructure composition was prepared by mixing and stirring the ingredients in Table 1 below according to their contents.
- the composition was poured into a mold and pressed with 1.5 to 5 tons for 5 to 300 seconds.
- the compressed preliminary microstructure was dried with hot air at 20°C to 70°C for 15 to 90 minutes. At this time, the solvent is removed during drying.
- the dried preliminary microstructure was separated from the mold and pulverized with a hammer mill to obtain microstructures satisfying an average length of 100 to 500 ⁇ m and an average diameter of 100 to 500 ⁇ m.
- caprylic glycol 0.0465 Acetylhexapeptide-8 0.00465 Sodium Hyaluronate 57.10779 lactose 16.27665 glycerin 16.27665 Port marigold flower extract 0.00093 1,2-hexanediol 0.0372 Licorice root extract 0.0186 Propanediol 7.44075 caprylyl glycol 1.39514 Ethylhexylglycerin 0.46505 Madecassoside 0.93009
- Preparation Example 1 The microstructure of Preparation Example 1 was mixed with the ingredients shown in Table 2 below according to their contents, heated to 60 to 80°C, and then passed through a high-pressure homogenizer to sufficiently mix. Cooling was performed at 30 to 45°C and then defoamed to prepare an oil gel-type cosmetic composition.
- Preparation Example 1 The microstructure of Preparation Example 1 was mixed with an aqueous base solvent containing the ingredients shown in Table 3 below.
- a water-based cosmetic composition was prepared at a mixing ratio of 30 parts by weight based on 100 parts by weight of the water-based base.
- composition content Purified water 48.9200 Purified water 100.0000 1.0% Sodium Hyaluronate Solution 25.0000 Purified water 98.2500 Sodium Hyaluronate 1.0000 Phenoxyethanol 0.17500 Ethylhexylglycerin 0.0500 glycerin 5.0000 glycerin 100.0000 Zilgel Oil 4.0000 Purified water 55.0000 glycerin 43.0000 Sodium polyacrylate 1.0000 PVM/MA copolymer 1.0000 Niacinamide 2.0000 Niacinamide 100.0000 MS ⁇ -PGA 0.5% 2.0000 Purified water 62.5000 Butylene glycol 35.0000 1,2-hexanediol 2.0000 polyglutamic acid 0.5000 Phyto HA 2.0000 Purified water 88.0000 Butylene glycol 10.0000 Phenoxyethanol 1.0000 White-throated mushroom sporangia extract 1.0000 Butylene glycol 2.0000 Butylene glycol 100.0000 1,2-hexanediol 1.5000 1,2-hex
- a microneedle patch was manufactured by attaching the microstructure of Preparation Example 1 to an adhesive sheet.
- the degree of skin irritation of the cosmetic compositions according to Examples and Comparative Examples was confirmed.
- the degree of skin irritation over time was observed in 50 healthy men and women using the example on one cheek and the comparative example on the other cheek.
- the judgment criteria and results are shown in Table 4.
- the Examples can provide similar absorption speed and shine as the Comparative Example.
- Excellent absorption rate and absorption speed which are advantages of using existing needle-type microstructures, can be provided at a similar level.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Dermatology (AREA)
- Emergency Medicine (AREA)
- Cosmetics (AREA)
- Physics & Mathematics (AREA)
- Geometry (AREA)
Abstract
La présente invention concerne une composition cosmétique et un procédé de préparation de celle-ci. Le produit cosmétique microstructuré peut injecter plus efficacement un agent actif dans la peau sans douleur ni irritation de la peau.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR10-2022-0077651 | 2022-06-24 | ||
KR1020220077651A KR102585994B1 (ko) | 2022-06-24 | 2022-06-24 | 화장료 조성물 및 이의 제조 방법 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2023249158A1 true WO2023249158A1 (fr) | 2023-12-28 |
Family
ID=88296003
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/KR2022/010367 WO2023249158A1 (fr) | 2022-06-24 | 2022-07-15 | Composition de polyéthylène et son procédé de sa préparation |
Country Status (2)
Country | Link |
---|---|
KR (1) | KR102585994B1 (fr) |
WO (1) | WO2023249158A1 (fr) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR102640649B1 (ko) * | 2023-11-28 | 2024-02-28 | 주식회사 쌤시크코스메틱 | 판테놀이 함유된 기능성 화장료 조성물 |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100834484B1 (ko) * | 2006-12-28 | 2008-06-09 | 주식회사 엘지생활건강 | 식물 혼합 추출물인 셀리언스를 함유하는 오일형 화장료조성물 |
KR101873337B1 (ko) * | 2017-01-02 | 2018-07-02 | 오한선 | 미세 타공이 형성된 하이드로겔 패치의 제조방법 및 이에 의해 제조된 하이드로겔 패치 |
KR20220038822A (ko) * | 2016-03-01 | 2022-03-29 | 조지아 테크 리서치 코오포레이션 | 마이크로니들 입자, 조성물, 및 치료방법 및 관심 물질 전달방법 |
KR20220085373A (ko) * | 2020-12-15 | 2022-06-22 | (주) 디에스테크 | 마이크로 구조체 및 이의 제조 방법 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR102409490B1 (ko) | 2020-07-03 | 2022-06-16 | 한남대학교 산학협력단 | 국소피부용 마이크로니들 및 이의 제조방법 |
-
2022
- 2022-06-24 KR KR1020220077651A patent/KR102585994B1/ko active IP Right Grant
- 2022-07-15 WO PCT/KR2022/010367 patent/WO2023249158A1/fr unknown
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100834484B1 (ko) * | 2006-12-28 | 2008-06-09 | 주식회사 엘지생활건강 | 식물 혼합 추출물인 셀리언스를 함유하는 오일형 화장료조성물 |
KR20220038822A (ko) * | 2016-03-01 | 2022-03-29 | 조지아 테크 리서치 코오포레이션 | 마이크로니들 입자, 조성물, 및 치료방법 및 관심 물질 전달방법 |
KR101873337B1 (ko) * | 2017-01-02 | 2018-07-02 | 오한선 | 미세 타공이 형성된 하이드로겔 패치의 제조방법 및 이에 의해 제조된 하이드로겔 패치 |
KR20220085373A (ko) * | 2020-12-15 | 2022-06-22 | (주) 디에스테크 | 마이크로 구조체 및 이의 제조 방법 |
Non-Patent Citations (1)
Title |
---|
"Recommendation PW Solution Celeb Ampoule-It's Mild and Moisturizing Without Irritation", 19 September 2018 (2018-09-19), Retrieved from the Internet <URL:https://blog.naver.com/grb5735/221362173663> * |
Also Published As
Publication number | Publication date |
---|---|
KR102585994B1 (ko) | 2023-10-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN108904302B (zh) | 水溶性富勒烯外用组合物 | |
WO2017052267A1 (fr) | Composition comprenant des vésicules extracellulaires dérivées d'extrait de plante destinée à l'état de la peau et à prévenir la perte de cheveux | |
JP3926711B2 (ja) | 表皮の偏平化を予防、防止、改善する皮膚老化防止用組成物 | |
JP2005220084A (ja) | アセロラ種子抽出物含有組成物 | |
KR101763373B1 (ko) | 식물 추출물을 유효성분으로 함유하는 화장료 조성물 | |
WO2018164309A1 (fr) | Composition cosmétique comprenant un extrait d'onagre | |
US20090061030A1 (en) | Cosmetic material containing swee pea extract | |
KR102310170B1 (ko) | 피부 상태 개선용 화장료 조성물 및 이의 제조방법 | |
WO2023249158A1 (fr) | Composition de polyéthylène et son procédé de sa préparation | |
JP2003201229A (ja) | マトリックスメタロプロテアーゼ活性阻害剤および抗老化用化粧料 | |
JP2006028148A (ja) | 外用組成物 | |
JP3791775B2 (ja) | 皮膚外用剤 | |
EP3777825A1 (fr) | Composition de formulation lyophilisée, kit cosmétique pour usage externe sur la peau la comprenant et son utilisation | |
KR101419588B1 (ko) | 홍삼 오일을 유효성분으로 함유하는 피부 보습용 조성물 | |
KR102283326B1 (ko) | 락토바실러스발효물, 락토코쿠스발효물, 효모폴리펩타이드, 락토바실러스 아시도필루스 포도발효물을 유효성분으로 하는 화장료 조성물 | |
KR102022230B1 (ko) | 피부 흡수 증진을 위한 에멀젼 구조 및 이의 제조방법 | |
JP2007045733A (ja) | ヒアルロニダーゼ阻害剤 | |
KR101953676B1 (ko) | 악마의 발톱 초음파 추출물을 함유하는 피부 보습용 화장료 조성물 | |
JP3660833B2 (ja) | 血行促進剤 | |
KR102247589B1 (ko) | 모루셀라 추출물 및 께묵 추출물을 유효 성분으로 포함하는 피부 개선용 화장료 조성물 | |
WO2024135943A1 (fr) | Procédé de fabrication d'une microstructure et microstructure ainsi fabriquée | |
WO2018194359A1 (fr) | Composition améliorant la peau | |
WO2016171482A1 (fr) | Composition cosmétique comprenant un extrait d'apitoxine, et son procédé de fabrication | |
JP4716497B2 (ja) | 皮膚外用剤およびヒアルロニダーゼ阻害剤 | |
KR101436819B1 (ko) | 피부 보습, 진정 및 여드름 개선용 화장료 조성물 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 22948092 Country of ref document: EP Kind code of ref document: A1 |